Patent ID: 6841684

Claim:
A compound selected from the group consisting of: wherein R 1 is independently selected from the group consisting of H; halogen; C 1-4 alkyl; C 1-4 alkenyl; C 1-4 alkynyl; —COR 4 where R 4 is H, C 1-4 alkyl or C 1-4 alkoxy; C 3-6 cycloalkyl; aryl; cyano; nitro; trihalomethyl; oxo; or —(CH 2 ) n —X—(CH 2 ) m —(R 5 ) o — where X is O, S or N, n is 0-3, m is 0-3, o is 0-1, and R 5 is methyl or H 1-2 , each R 6 is independent selected from the group consisting of H; halogen; C 1-4 alkyl; C 1-4 alkenyl; C 1-4 alkynyl; —COR 4 where R 4 is H, C 1-4 alkyl or C 1-4 alkoxy; C 3-6 cycloalkyl; aryl; cyano; nitro; trihalomethyl and oxo wherein each p is independently 1 or 2 and Y is —(C(R 7 ) z ) 2 —, wherein R 7 is independently defined identically to R 1 and z is independently 1 or 2, said compound further having selective agonist activity at the α2B or α2B/α2C adrenergic receptor subtype(s) over the α2A adrenergic receptor subtype, and all pharmacologically acceptable salts, esters, stereoisomers and racemic mixtures thereof.